A phase II trial of intratumoral injection with a selectively replicating adenovirus (ONYX-015) in patients with recurrent, refractory squamous cell carcinoma of the head and neck
Dh. Kirn, A phase II trial of intratumoral injection with a selectively replicating adenovirus (ONYX-015) in patients with recurrent, refractory squamous cell carcinoma of the head and neck, METH MOL M, 35, 2000, pp. 559-574